year, due to the delay approval process of budget expenditure of the government for the 2020 fiscal year. - Revenues from sales and beauty treatment services in Q2/2020 were THB 4 million decreased by 92

Microsoft Word - 2019 Results Notification letter_Eng _Final_ February 11, 2020 The Director and Manager The Stock Exchange of Thailand Re: Information concerning Fiscal Year 2019 Operating Results

) Resolved propose to the Annual Ordinary General Meeting of Shareholders to consider and approve the Balance Sheet and Profit and Loss Statement of the Company for the fiscal year ended December 31, 2017

will be made on May 24, 2019. The mentioned right will be further approved by the AGM 2019. 2. Approved to propose to the AGM to consider and approve the financial statement of the company for the fiscal

Consolidated Financial Results 1. Operating Results Revenues In the first half of fiscal year 2021, the total consolidated revenues were 10,386 million baht, decreasing of 655 million baht or 6% y-y. In the

accounts of 10,772 million baht or 12% of total accounts receivable, decreasing from 10,951 million baht or 12% of total accounts receivable at the end of previous fiscal year. For default receivables in

10,470 million baht or 11% of total accounts receivable, comparing to that of 10,951 million baht or 12% of total accounts receivable at the end of previous fiscal year. The delinquent account receivables

reduction in personal loan receivable by 517 million baht or 1% from end of last fiscal year. The main assets were attributed to the portfolio of net account receivables which shared 99% of total assets

No: AH 04052024 May 14th, 2024 Subject: Management Discussion & Analysis (MD&A) for the Financial Statements of the 1st Quarter of Fiscal Year 2024 Ended as of March 31, 2024 To: The President The

IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited